Rare diseases
Investigational molecules
Locations
Long‑Term Safety, Tolerability and Efficacy of Azetukalner in Patients with Major Depressive Disorder
FinlandLong‑term Safety and Tolerability of Admilparant in Adults with Idiopathic or Progressive Pulmonary Fibrosis
FinlandTranexamic Acid versus Placebo for Reducing Infection after Mid‑and Hind‑Foot Arthrodesis in Adults with Deformity or Osteoarthritis
FinlandA study comparing the effects of estetrol and drospirenone, ethinylestradiol and drospirenone, and drospirenone in women with polycystic ovary syndrome (PCOS)
FinlandContraception study in women: comparing oral drospirenone‑only, drospirenone + ethinylestradiol, and drospirenone + estetrol tablets
FinlandComparing local gentamicin or vancomycin hydrochloride to a drug combination for patients with diabetic foot osteomyelitis
FinlandA study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis
FinlandA study to evaluate the effectiveness and safety of admilparant in patients with idiopathic pulmonary fibrosis
FinlandFinlandA study testing dapagliflozin and SC0062 together compared to SC0062 alone in adults with type 1 diabetes and chronic kidney disease
FinlandA study of azetukalner compared to placebo for adults with moderate-to-severe major depressive disorder
FinlandA Study of Isosorbide Mononitrate for Patients with Normal Tension Glaucoma to Improve Blood Flow to the Optic Nerve
FinlandTell us about your condition – we search every trial in Europe and connect you with the right site.
